{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:42:37Z","timestamp":1774305757070,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.7759\/cureus.62363","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:39:00Z","timestamp":1718365140000},"source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence"],"prefix":"10.7759","author":[{"given":"Nobuo","family":"Okui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko A","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.01.045","article-title":"European Association of Urology Guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence","volume":"82","author":"Nambiar AK","year":"2022","unstructured":"Nambiar AK, Arlandis S, B\u00f8 K, et al.. European Association of Urology Guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022, 82:49-59. 10.1016\/j.eururo.2022.01.045","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025761","article-title":"Effects of overactive bladder syndrome on female sexual function","volume":"100","author":"Lin XD","year":"2021","unstructured":"Lin XD, Lin N, Ke ZB, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine (Baltimore). 2021, 100:e25761. 10.1097\/MD.0000000000025761","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2019.05.002","article-title":"Impact of overactive bladder-wet syndrome on female sexual function: a systematic review and meta-analysis","volume":"7","author":"Balzarro M","year":"2019","unstructured":"Balzarro M, Rubilotta E, Mancini V, et al.. Impact of overactive bladder-wet syndrome on female sexual function: a systematic review and meta-analysis. Sex Med Rev. 2019, 7:565-74. 10.1016\/j.sxmr.2019.05.002","journal-title":"Sex Med Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.04.084","article-title":"Mixed incontinence masked as stress induced urgency urinary incontinence","volume":"196","author":"Minassian VA","year":"2016","unstructured":"Minassian VA, Yan XS, Pitcavage J, Stewart WF. Mixed incontinence masked as stress induced urgency urinary incontinence. J Urol. 2016, 196:1190-5. 10.1016\/j.juro.2016.04.084","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001380","article-title":"Risk factors for de novo overactive bladder after midurethral sling","volume":"30","author":"Serna-Gallegos T","year":"2024","unstructured":"Serna-Gallegos T, Dutta S, Crowder C, Wadensweiler P, Whitcomb EL, Guaderrama NM. Risk factors for de novo overactive bladder after midurethral sling. Urogynecology (Phila). 2024, 30:59-64. 10.1097\/SPV.0000000000001380","journal-title":"Urogynecology (Phila)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-021-03317-x","article-title":"Comparison of urethral sling surgery and non-ablative vaginal erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis","volume":"37","author":"Okui N","year":"2022","unstructured":"Okui N, Miyazaki H, Takahashi W, et al.. Comparison of urethral sling surgery and non-ablative vaginal erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis. Lasers Med Sci. 2022, 37:655-63. 10.1007\/s10103-021-03317-x","journal-title":"Lasers Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45495","article-title":"Vaginal laser treatment for the genitourinary syndrome of menopause in breast cancer survivors: a narrative review","volume":"15","author":"Okui N","year":"2023","unstructured":"Okui N. Vaginal laser treatment for the genitourinary syndrome of menopause in breast cancer survivors: a narrative review. Cureus. 2023, 15:e45495. 10.7759\/cureus.45495","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-016-1884-0","article-title":"Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study","volume":"31","author":"Fistoni\u0107 N","year":"2016","unstructured":"Fistoni\u0107 N, Fistoni\u0107 I, Gu\u0161tek \u0160F, et al.. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci. 2016, 31:635-43. 10.1007\/s10103-016-1884-0","journal-title":"Lasers Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2445-x","article-title":"Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence","volume":"37","author":"Okui N","year":"2019","unstructured":"Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 2019, 37:885-9. 10.1007\/s00345-018-2445-x","journal-title":"World J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22826","article-title":"Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study","volume":"50","author":"Gaspar A","year":"2018","unstructured":"Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, Vi\u017eintin Z. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Lasers Surg Med. 2018, 50:802-7. 10.1002\/lsm.22826","journal-title":"Lasers Surg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36730","article-title":"Long-term improvement in urinary incontinence in an elite female athlete through the laser treatment: a case report","volume":"15","author":"Okui N","year":"2023","unstructured":"Okui N, Ikegami T, Mikic AN, Okui M, Gaspar A. Long-term improvement in urinary incontinence in an elite female athlete through the laser treatment: a case report. Cureus. 2023, 15:e36730. 10.7759\/cureus.36730","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2023.2210282","article-title":"SUI in postmenopausal women: advantages of an intraurethral\u2009+\u2009intravaginal Er:YAG laser","volume":"26","author":"Erel CT","year":"2023","unstructured":"Erel CT, Gambacciani M, Ozcivit Erkan IB, Gokmen Inan N, Hamzaoglu Canbolat K, Fidecicchi T. SUI in postmenopausal women: advantages of an intraurethral\u2009+\u2009intravaginal Er:YAG laser. Climacteric. 2023, 26:503-9. 10.1080\/13697137.2023.2210282","journal-title":"Climacteric"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44364","article-title":"Analysis of predictive factors for return to sports in female athletes with stress urinary incontinence","volume":"15","author":"Okui N","year":"2023","unstructured":"Okui N, Erel T, Okui MA. Analysis of predictive factors for return to sports in female athletes with stress urinary incontinence. Cureus. 2023, 15:e44364. 10.7759\/cureus.44364","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51431","article-title":"Mesh extraction surgery and laser treatment for pain after mid-urethral sling surgery: a case series","volume":"16","author":"Okui N","year":"2024","unstructured":"Okui N, Okui MA. Mesh extraction surgery and laser treatment for pain after mid-urethral sling surgery: a case series. Cureus. 2024, 16:e51431. 10.7759\/cureus.51431","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000584","article-title":"Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women","volume":"31","author":"Wallace SL","year":"2019","unstructured":"Wallace SL, Miller LD, Mishra K. Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women. Curr Opin Obstet Gynecol. 2019, 31:485-93. 10.1097\/GCO.0000000000000584","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58030383","article-title":"Prevalence of and associated factors for overactive bladder subtypes in middle-aged women: a cross-sectional study","volume":"58","author":"Yang CF","year":"2022","unstructured":"Yang CF, Huang CY, Wang SY, Chang SR. Prevalence of and associated factors for overactive bladder subtypes in middle-aged women: a cross-sectional study. Medicina (Kaunas). 2022, 58:383. 10.3390\/medicina58030383","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.06.044","article-title":"Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score","volume":"77","author":"Homma Y","year":"2011","unstructured":"Homma Y, Kakizaki H, Yamaguchi O, et al.. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology. 2011, 77:60-4. 10.1016\/j.urology.2010.06.044","journal-title":"Urology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.02237.x","article-title":"Psychometric validation of the Japanese version of the International Consultation on Incontinence Questionnaire-Short Form","volume":"16","author":"Gotoh M","year":"2009","unstructured":"Gotoh M, Homma Y, Funahashi Y, Matsukawa Y, Kato M. Psychometric validation of the Japanese version of the International Consultation on Incontinence Questionnaire-Short Form. Int J Urol. 2009, 16:303-6. 10.1111\/j.1442-2042.2008.02237.x","journal-title":"Int J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5213\/inj.1836212.106","article-title":"Urodynamic and bladder diary factors predict overactive bladder-wet in women: a comparison with overactive bladder-dry","volume":"23","author":"Hsiao SM","year":"2019","unstructured":"Hsiao SM, Wu PC, Chang TC, Chen CH, Lin HH. Urodynamic and bladder diary factors predict overactive bladder-wet in women: a comparison with overactive bladder-dry. Int Neurourol J. 2019, 23:69-74. 10.5213\/inj.1836212.106","journal-title":"Int Neurourol J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38604","article-title":"Efficacy of two laser treatment strategies for breast cancer survivors with genitourinary syndrome of menopause","volume":"15","author":"Okui N","year":"2023","unstructured":"Okui N, Okui M, Kouno Y, Nakano K, Gambacciani M. Efficacy of two laser treatment strategies for breast cancer survivors with genitourinary syndrome of menopause. Cureus. 2023, 15:e38604. 10.7759\/cureus.38604","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.12.008","article-title":"Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder","volume":"83","author":"Yokoyama O","year":"2014","unstructured":"Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H. Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Urology. 2014, 83:750-5. 10.1016\/j.urology.2013.12.008","journal-title":"Urology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0924-4","article-title":"Mirabegron: a review in overactive bladder syndrome","volume":"78","author":"Deeks ED","year":"2018","unstructured":"Deeks ED. Mirabegron: a review in overactive bladder syndrome. Drugs. 2018, 78:833-44. 10.1007\/s40265-018-0924-4","journal-title":"Drugs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23935","article-title":"Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: a randomized, prospective trial using urodynamic studies","volume":"38","author":"Matsukawa Y","year":"2019","unstructured":"Matsukawa Y, Takai S, Majima T, et al.. Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: a randomized, prospective trial using urodynamic studies. Neurourol Urodyn. 2019, 38:941-9. 10.1002\/nau.23935","journal-title":"Neurourol Urodyn"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1847-x","article-title":"Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement","volume":"35","author":"Giannantoni A","year":"2017","unstructured":"Giannantoni A, Carbone A, Carone R, et al.. Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement. World J Urol. 2017, 35:299-306. 10.1007\/s00345-016-1847-x","journal-title":"World J Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S89544","article-title":"Sacral neuromodulation in overactive bladder: a review and current perspectives","volume":"8","author":"Sukhu T","year":"2016","unstructured":"Sukhu T, Kennelly MJ, Kurpad R. Sacral neuromodulation in overactive bladder: a review and current perspectives. Res Rep Urol. 2016, 8:193-9. 10.2147\/RRU.S89544","journal-title":"Res Rep Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24864","article-title":"Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis\/painful bladder syndrome: a systematic review and meta-analysis","volume":"41","author":"Ghavidel-Sardsahra A","year":"2022","unstructured":"Ghavidel-Sardsahra A, Ghojazadeh M, Rahnama'I MS, et al.. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis\/painful bladder syndrome: a systematic review and meta-analysis. Neurourol Urodyn. 2022, 41:539-51. 10.1002\/nau.24864","journal-title":"Neurourol Urodyn"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02644-7","article-title":"Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and \u03b23-adrenoceptor agonists","volume":"37","author":"Okui N","year":"2019","unstructured":"Okui N. Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and \u03b23-adrenoceptor agonists. World J Urol. 2019, 37:2459-66. 10.1007\/s00345-019-02644-7","journal-title":"World J Urol"},{"key":"ref28","article-title":"Er-YAG laser treatment of OAB","author":"Gambacciani M","year":"2023","unstructured":"Gambacciani M, Okui PN. Er-YAG laser treatment of OAB. Latest Perspective in OAB Treatment. Giannantoni A (ed): Edizioni Minerva Medica, Torino, Italy; 2023. 171-81."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002159","article-title":"Efficacy of erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial","volume":"30","author":"Chiengthong K","year":"2023","unstructured":"Chiengthong K, Bunyavejchevin S. Efficacy of erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial. Menopause. 2023, 30:414-20. 10.1097\/GME.0000000000002159","journal-title":"Menopause"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08498.x","article-title":"Symptom severity and patient perceptions in overactive bladder: how are they related?","volume":"104","author":"Homma Y","year":"2009","unstructured":"Homma Y, Gotoh M. Symptom severity and patient perceptions in overactive bladder: how are they related?. BJU Int. 2009, 104:968-72. 10.1111\/j.1464-410X.2009.08498.x","journal-title":"BJU Int"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.4020","article-title":"Industry payments for vibegron and prescribing patterns among urologic clinicians","volume":"4","author":"Polcari K","year":"2023","unstructured":"Polcari K, Hyman MJ, Skolarus TA, Sales AE, Meltzer DO, Modi PK. Industry payments for vibegron and prescribing patterns among urologic clinicians. JAMA Health Forum. 2023, 4:e234020. 10.1001\/jamahealthforum.2023.4020","journal-title":"JAMA Health Forum"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034582","article-title":"Efficacy of biofeedback, repetitive transcranial magnetic stimulation and pelvic floor muscle training for female neurogenic bladder dysfunction after spinal cord injury: a study protocol for a randomised controlled trial","volume":"10","author":"Xu L","year":"2020","unstructured":"Xu L, Fu C, Zhang Q, et al.. Efficacy of biofeedback, repetitive transcranial magnetic stimulation and pelvic floor muscle training for female neurogenic bladder dysfunction after spinal cord injury: a study protocol for a randomised controlled trial. BMJ Open. 2020, 10:e034582. 10.1136\/bmjopen-2019-034582","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260159-efficacy-and-safety-of-combination-therapy-with-vaginal-and-urethral-erbium-doped-yttrium-aluminum-garnet-eryag-laser-for-overactive-bladder-with-urinary-incontinence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:39:04Z","timestamp":1718365144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260159-efficacy-and-safety-of-combination-therapy-with-vaginal-and-urethral-erbium-doped-yttrium-aluminum-garnet-eryag-laser-for-overactive-bladder-with-urinary-incontinence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.62363","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}